Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Hematology and Cell Therapy
Published in: Hematology and Cell Therapy 2-3/2000

01-09-2000 | Original articles

VECP-Bleo regimen as treatment of advanced stage aggressive non-Hodgkin’s Lymphoma in elderly patients a GOELAMS protocol

Authors: N. Raban, B. Giraudeau, B. Desablens, L. Sensebe, V. Delwail, Ch. Foussard, Th. Lamy, J. Dugay, M. Reisenleiter, Ph. Rodon, J. B. Gauvin, Ph. Colombat

Published in: Hematology and Cell Therapy | Issue 2-3/2000

Login to get access
Metadata
Title
VECP-Bleo regimen as treatment of advanced stage aggressive non-Hodgkin’s Lymphoma in elderly patients a GOELAMS protocol
Authors
N. Raban
B. Giraudeau
B. Desablens
L. Sensebe
V. Delwail
Ch. Foussard
Th. Lamy
J. Dugay
M. Reisenleiter
Ph. Rodon
J. B. Gauvin
Ph. Colombat
Publication date
01-09-2000
Publisher
Springer-Verlag
Published in
Hematology and Cell Therapy / Issue 2-3/2000
Print ISSN: 1269-3286
Electronic ISSN: 1279-8509
DOI
https://doi.org/10.1007/s00282-000-0142-9

Other articles of this Issue 2-3/2000

Hematology and Cell Therapy 2-3/2000 Go to the issue

Original articles

Cost analysis of allogeneic bone marrow transplantation

Case reports

Hydroxyurea-associated pneumonitis

Original articles

Allogeneic bone marrow tranplantation for young adult patients with newly diagnosed acute myeloid leukemia: HLA-Matched sibling donor availability does not improve treatment ouctome

Original articles

Imbalance between the number of patients supplying stem cells for autologous transplantation and the number of patients receiving such transplants in France in 1997 and 1998

Case reports

Subcutaneous lymphoblastic lymphomas. Expression of cellular adhesion molecules: 2 cases

Case reports

Red Blood Cells (RBC) and High Fluorescence Reticulocytes (HFR) production increased by induction chemotherapy and GM-CSF plus G-CSF in peripheral blood of breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits